{"id":435,"date":"2018-07-12T09:01:58","date_gmt":"2018-07-12T14:01:58","guid":{"rendered":"https:\/\/www.caribbeanvalueinvestor.com\/news\/?p=435"},"modified":"2018-07-12T09:06:24","modified_gmt":"2018-07-12T14:06:24","slug":"indies-pharma-ipo","status":"publish","type":"post","link":"https:\/\/www.caribbeanvalueinvestor.com\/news\/ipos\/indies-pharma-ipo\/","title":{"rendered":"Indies Pharma IPO- Is it a buy?"},"content":{"rendered":"<h1 style=\"text-align: center;\">Indies Pharma IPO<\/h1>\n<p>Indies Pharma Jamaica Limited markets and distributes prescription and non-prescription generic pharmaceutical products throughout Jamaica covering more than 21 disease segments. More than 150 drugs are offered allowing the company to benefit from diversified revenue stream with no single range of products accounting for more than 12.5% of revenues. On average the company has introduced 10 \u2013 15 products per year. Indies Pharma is focused on marketing and distributing the Bioprist brand of generic pharmaceutical products which is owned and licensed by its holding company, Bioprist Holdings, a company which is incorporated in St. Lucea. According to the prospectus \u201cthe products distributed by the Company are contract manufactured for and supplied to the Bioprist Group by 12 contract manufacturing pharmaceutical companies from India and Bangladesh, and then onto the Company for non-exclusive distribution\u201d. Indies Pharma prides itself on quality customer services, efficient and effective product movement. To this end the company can deliver products within 24 to 48 hours upon receipt of a purchase order.<\/p>\n<p><em>Advertisement<\/em><br \/>\n<script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js\"><\/script><br \/>\n<ins class=\"adsbygoogle\" style=\"display: block; text-align: center;\" hidden=\"\" data-ad-layout=\"in-article\" data-ad-format=\"fluid\" data-ad-client=\"ca-pub-8845932375528187\" data-ad-slot=\"9931797745\"><\/ins><br \/>\n<script>\n     (adsbygoogle = window.adsbygoogle || []).push({});\n<\/script><\/p>\n<p>Indies Pharma Initial Public Offering (IPO) is seeking JMD $387,216,970.05 for 266,507,330 shares of which 39,500,000 are for the general public at a price of JMD $1.50. The COO Vishnu Muppuri will be selling 92,534,181 shares at a value of JMD $138,786,000. The remaining funds of about JMD $248,430,000 will be used by the company for debt repayment and working capital. The company owes about JMD $194,031,314 of debt which will be cleared by the IPO. Base on 2017 audited financials this would cut the finance cost by more than $15 million and along with the tax benefits that would be gained from listing on the Junior market, add a further $35 million to the profits. Base on these factors and the compound annual growth rate of 22.1% that was given for revenues, an EPS of around JMD $0.16 is possible within the next 12 months. Current metrics can be viewed below.<\/p>\n<p>Earns per share $0.10<br \/>\nPrice to Earnings Ratio 14.56<br \/>\nBook Value $0.28<br \/>\nReturn on equity 37%<br \/>\nReturn on asset 22%<br \/>\nDebt to equity ratio 67%<\/p>\n<p><a href=\"https:\/\/www.caribbeanvalueinvestor.com\/news\/wp-content\/uploads\/2018\/07\/Indies-Pharma-IPO-Graph.png\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-438\" src=\"https:\/\/www.caribbeanvalueinvestor.com\/news\/wp-content\/uploads\/2018\/07\/Indies-Pharma-IPO-Graph.png\" alt=\"Indies Pharma IPO Graph\" width=\"868\" height=\"449\" srcset=\"https:\/\/www.caribbeanvalueinvestor.com\/news\/wp-content\/uploads\/2018\/07\/Indies-Pharma-IPO-Graph.png 868w, https:\/\/www.caribbeanvalueinvestor.com\/news\/wp-content\/uploads\/2018\/07\/Indies-Pharma-IPO-Graph-300x155.png 300w, https:\/\/www.caribbeanvalueinvestor.com\/news\/wp-content\/uploads\/2018\/07\/Indies-Pharma-IPO-Graph-768x397.png 768w\" sizes=\"auto, (max-width: 868px) 100vw, 868px\" \/><\/a><\/p>\n<p>The company appears to have fairly valued metrics which indicates that the company can be bought with the expectation of a short-term benefit from the tax incentives that will be received. Over the past 5 years, Indies Pharma has demonstrated consistent net profit earnings. The last three years show tremendous growth as the image above displays. However, the company is not without challenges. With such a diverse array of products, the question that Indies Pharma must answer is if they can control their cost of goods sold (COGS) and achieve a timely inventory turnover. The company is restricted in marketing as local laws prevent the company from advertising prescription drugs.<\/p>\n<p>Advertisement<br \/>\n<script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js\"><\/script><br \/>\n<ins class=\"adsbygoogle\" style=\"display: block; text-align: center;\" hidden=\"\" data-ad-layout=\"in-article\" data-ad-format=\"fluid\" data-ad-client=\"ca-pub-8845932375528187\" data-ad-slot=\"9931797745\"><\/ins><br \/>\n<script>\n     (adsbygoogle = window.adsbygoogle || []).push({});\n<\/script><br \/>\nTherefore, the cost to acquire customer in this competitive environment may increase due to the company being forced to engaged in indirect marketing through representatives that interact with the doctors to promote their products. Customers therefore are left with no power in suggesting their preferred medication. Indies Pharma would be the second pharmaceutical company to be listed (<a href=\"https:\/\/www.caribbeanvalueinvestor.com\/news\/jamaica-stock-exchange\/the-case-of-pfizer-vs-lasco-distributors-prt-1\/\">the other being Lasco Pharmaceuticals under Lasco Distributors<\/a>) on the Junior market.<\/p>\n<p><em>Suggested Reading<\/em>:<a href=\"https:\/\/www.caribbeanvalueinvestor.com\/news\/jamaica-stock-exchange\/the-case-of-pfizer-vs-lasco-distributors-prt-1\/\"> The Case of Pfizer vs Lasco Distributors<\/a><\/p>\n<p>With the Indies Pharma IPO offer being fairly valued and only JMD $387,216,970.05 being sought\u00a0 with 39,500,000 shares available for the general public, the IPO is relatively small. Against this backdrop, <strong>Caribbbean Value Investor<\/strong> expects the Indies Pharma IPO to be oversubscribed. The lead broker for the Indies Pharma IPO is <strong>GK Capital Management Limited<\/strong> and the co-broker is <strong>Sagicor Investment Jamaica Limited.<\/strong><\/p>\n<p><strong>Disclaimer: The opinions expressed in this article are solely those of the author (s) and are in no way intended to reflect management&#8217;s views. Further, all information provided on Caribbean Value Investor is strictly for educational purposes. Caribbean Value Investor, its Directors, Employees and Stakeholders accept no liability in respect to gains or losses experienced by readers.<\/strong><\/p>\n<p><span style=\"border-radius: 2px; text-indent: 20px; width: auto; padding: 0px 4px 0px 0px; text-align: center; font: bold 11px\/20px 'Helvetica Neue',Helvetica,sans-serif; color: #ffffff; background: #bd081c  no-repeat scroll 3px 50% \/ 14px 14px; position: absolute; opacity: 1; z-index: 8675309; display: none; cursor: pointer;\">Save<\/span><\/p>\n\n<div class=\"twitter-share\"><a href=\"https:\/\/twitter.com\/intent\/tweet?via=cvijamaica\" class=\"twitter-share-button\" data-size=\"large\">Tweet<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Indies Pharma IPO Indies Pharma Jamaica Limited markets and distributes prescription and non-prescription generic pharmaceutical products throughout Jamaica covering more<\/p>\n","protected":false},"author":4,"featured_media":441,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3,182,18,5,11,17,148],"tags":[34,185,183,178,111,184,187,179,186,149],"class_list":["post-435","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-financials","category-ipos","category-jamaica","category-jamaica-stock-exchange","category-jse","category-retailers","category-stock-market-analysis","tag-caribbean-value-investor","tag-gk-investments","tag-indies-pharma","tag-ipo","tag-jamaica","tag-jamaican-stock-exchange","tag-pharmaceuticals","tag-prospectus","tag-sagicor-investments","tag-stock-market-analysis"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v17.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Indies Pharma IPO- Is it a buy? - Caribbean Value Investor - Articles and Analysis<\/title>\n<meta name=\"description\" content=\"With the Indies Pharma IPO offer being fairly valued and only JMD $387,216,970.05 being sought with 39,500,000 shares available for the general public...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.caribbeanvalueinvestor.com\/news\/ipos\/indies-pharma-ipo\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Indies Pharma IPO- Is it a buy? - Caribbean Value Investor - Articles and Analysis\" \/>\n<meta property=\"og:description\" content=\"With the Indies Pharma IPO offer being fairly valued and only JMD $387,216,970.05 being sought with 39,500,000 shares available for the general public...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.caribbeanvalueinvestor.com\/news\/ipos\/indies-pharma-ipo\/\" \/>\n<meta property=\"og:site_name\" content=\"Caribbean Value Investor - Articles and Analysis\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Caribbean-Value-Investor-CVI-121800055170244\/\" \/>\n<meta property=\"article:published_time\" content=\"2018-07-12T14:01:58+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-07-12T14:06:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.caribbeanvalueinvestor.com\/news\/wp-content\/uploads\/2018\/07\/Indies-Pharma-IPO-logo-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"838\" \/>\n\t<meta property=\"og:image:height\" content=\"416\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@RandyAird\" \/>\n<meta name=\"twitter:site\" content=\"@cvijamaica\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Randy Aird\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.caribbeanvalueinvestor.com\/news\/#organization\",\"name\":\"Caribbean Value Investor\",\"url\":\"https:\/\/www.caribbeanvalueinvestor.com\/news\/\",\"sameAs\":[\"https:\/\/www.facebook.com\/Caribbean-Value-Investor-CVI-121800055170244\/\",\"https:\/\/www.instagram.com\/cvijamaica\/\",\"https:\/\/www.linkedin.com\/company\/27118746\/\",\"https:\/\/www.youtube.com\/channel\/UCiQAok16nPP1RLpfBW8wyJA?view_as=subscriber\",\"https:\/\/twitter.com\/cvijamaica\"],\"logo\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/www.caribbeanvalueinvestor.com\/news\/#logo\",\"inLanguage\":\"en\",\"url\":\"https:\/\/www.caribbeanvalueinvestor.com\/news\/wp-content\/uploads\/2017\/11\/wallpaper.png\",\"contentUrl\":\"https:\/\/www.caribbeanvalueinvestor.com\/news\/wp-content\/uploads\/2017\/11\/wallpaper.png\",\"width\":1920,\"height\":1080,\"caption\":\"Caribbean Value Investor\"},\"image\":{\"@id\":\"https:\/\/www.caribbeanvalueinvestor.com\/news\/#logo\"}},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.caribbeanvalueinvestor.com\/news\/#website\",\"url\":\"https:\/\/www.caribbeanvalueinvestor.com\/news\/\",\"name\":\"Caribbean Value Investor - Articles and Analysis\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.caribbeanvalueinvestor.com\/news\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.caribbeanvalueinvestor.com\/news\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en\"},{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/www.caribbeanvalueinvestor.com\/news\/ipos\/indies-pharma-ipo\/#primaryimage\",\"inLanguage\":\"en\",\"url\":\"https:\/\/www.caribbeanvalueinvestor.com\/news\/wp-content\/uploads\/2018\/07\/Indies-Pharma-IPO-logo-1.png\",\"contentUrl\":\"https:\/\/www.caribbeanvalueinvestor.com\/news\/wp-content\/uploads\/2018\/07\/Indies-Pharma-IPO-logo-1.png\",\"width\":838,\"height\":416,\"caption\":\"Indies Pharma IPO logo\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.caribbeanvalueinvestor.com\/news\/ipos\/indies-pharma-ipo\/#webpage\",\"url\":\"https:\/\/www.caribbeanvalueinvestor.com\/news\/ipos\/indies-pharma-ipo\/\",\"name\":\"Indies Pharma IPO- Is it a buy? - Caribbean Value Investor - Articles and Analysis\",\"isPartOf\":{\"@id\":\"https:\/\/www.caribbeanvalueinvestor.com\/news\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.caribbeanvalueinvestor.com\/news\/ipos\/indies-pharma-ipo\/#primaryimage\"},\"datePublished\":\"2018-07-12T14:01:58+00:00\",\"dateModified\":\"2018-07-12T14:06:24+00:00\",\"description\":\"With the Indies Pharma IPO offer being fairly valued and only JMD $387,216,970.05 being sought with 39,500,000 shares available for the general public...\",\"breadcrumb\":{\"@id\":\"https:\/\/www.caribbeanvalueinvestor.com\/news\/ipos\/indies-pharma-ipo\/#breadcrumb\"},\"inLanguage\":\"en\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.caribbeanvalueinvestor.com\/news\/ipos\/indies-pharma-ipo\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.caribbeanvalueinvestor.com\/news\/ipos\/indies-pharma-ipo\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.caribbeanvalueinvestor.com\/news\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Indies Pharma IPO- Is it a buy?\"}]},{\"@type\":\"Article\",\"@id\":\"https:\/\/www.caribbeanvalueinvestor.com\/news\/ipos\/indies-pharma-ipo\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.caribbeanvalueinvestor.com\/news\/ipos\/indies-pharma-ipo\/#webpage\"},\"author\":{\"@id\":\"https:\/\/www.caribbeanvalueinvestor.com\/news\/#\/schema\/person\/cf4242964f6fec93f62c5580d1ae8c10\"},\"headline\":\"Indies Pharma IPO- Is it a buy?\",\"datePublished\":\"2018-07-12T14:01:58+00:00\",\"dateModified\":\"2018-07-12T14:06:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.caribbeanvalueinvestor.com\/news\/ipos\/indies-pharma-ipo\/#webpage\"},\"wordCount\":631,\"commentCount\":1,\"publisher\":{\"@id\":\"https:\/\/www.caribbeanvalueinvestor.com\/news\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.caribbeanvalueinvestor.com\/news\/ipos\/indies-pharma-ipo\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.caribbeanvalueinvestor.com\/news\/wp-content\/uploads\/2018\/07\/Indies-Pharma-IPO-logo-1.png\",\"keywords\":[\"Caribbean Value Investor\",\"GK Investments\",\"Indies Pharma\",\"IPO\",\"Jamaica\",\"Jamaican Stock Exchange\",\"Pharmaceuticals\",\"Prospectus\",\"Sagicor Investments\",\"stock market analysis\"],\"articleSection\":[\"Financials\",\"IPOs\",\"Jamaica\",\"Jamaica Stock Exchange\",\"JSE\",\"Retailers\",\"stock market analysis\"],\"inLanguage\":\"en\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.caribbeanvalueinvestor.com\/news\/ipos\/indies-pharma-ipo\/#respond\"]}]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.caribbeanvalueinvestor.com\/news\/#\/schema\/person\/cf4242964f6fec93f62c5580d1ae8c10\",\"name\":\"Randy Aird\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/www.caribbeanvalueinvestor.com\/news\/#personlogo\",\"inLanguage\":\"en\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/544b04447358be67492969dc36891d4c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/544b04447358be67492969dc36891d4c?s=96&d=mm&r=g\",\"caption\":\"Randy Aird\"},\"sameAs\":[\"https:\/\/twitter.com\/RandyAird\"],\"url\":\"https:\/\/www.caribbeanvalueinvestor.com\/news\/author\/randy-aird\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Indies Pharma IPO- Is it a buy? - Caribbean Value Investor - Articles and Analysis","description":"With the Indies Pharma IPO offer being fairly valued and only JMD $387,216,970.05 being sought with 39,500,000 shares available for the general public...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.caribbeanvalueinvestor.com\/news\/ipos\/indies-pharma-ipo\/","og_locale":"en_US","og_type":"article","og_title":"Indies Pharma IPO- Is it a buy? - Caribbean Value Investor - Articles and Analysis","og_description":"With the Indies Pharma IPO offer being fairly valued and only JMD $387,216,970.05 being sought with 39,500,000 shares available for the general public...","og_url":"https:\/\/www.caribbeanvalueinvestor.com\/news\/ipos\/indies-pharma-ipo\/","og_site_name":"Caribbean Value Investor - Articles and Analysis","article_publisher":"https:\/\/www.facebook.com\/Caribbean-Value-Investor-CVI-121800055170244\/","article_published_time":"2018-07-12T14:01:58+00:00","article_modified_time":"2018-07-12T14:06:24+00:00","og_image":[{"width":838,"height":416,"url":"https:\/\/www.caribbeanvalueinvestor.com\/news\/wp-content\/uploads\/2018\/07\/Indies-Pharma-IPO-logo-1.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_creator":"@RandyAird","twitter_site":"@cvijamaica","twitter_misc":{"Written by":"Randy Aird","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Organization","@id":"https:\/\/www.caribbeanvalueinvestor.com\/news\/#organization","name":"Caribbean Value Investor","url":"https:\/\/www.caribbeanvalueinvestor.com\/news\/","sameAs":["https:\/\/www.facebook.com\/Caribbean-Value-Investor-CVI-121800055170244\/","https:\/\/www.instagram.com\/cvijamaica\/","https:\/\/www.linkedin.com\/company\/27118746\/","https:\/\/www.youtube.com\/channel\/UCiQAok16nPP1RLpfBW8wyJA?view_as=subscriber","https:\/\/twitter.com\/cvijamaica"],"logo":{"@type":"ImageObject","@id":"https:\/\/www.caribbeanvalueinvestor.com\/news\/#logo","inLanguage":"en","url":"https:\/\/www.caribbeanvalueinvestor.com\/news\/wp-content\/uploads\/2017\/11\/wallpaper.png","contentUrl":"https:\/\/www.caribbeanvalueinvestor.com\/news\/wp-content\/uploads\/2017\/11\/wallpaper.png","width":1920,"height":1080,"caption":"Caribbean Value Investor"},"image":{"@id":"https:\/\/www.caribbeanvalueinvestor.com\/news\/#logo"}},{"@type":"WebSite","@id":"https:\/\/www.caribbeanvalueinvestor.com\/news\/#website","url":"https:\/\/www.caribbeanvalueinvestor.com\/news\/","name":"Caribbean Value Investor - Articles and Analysis","description":"","publisher":{"@id":"https:\/\/www.caribbeanvalueinvestor.com\/news\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.caribbeanvalueinvestor.com\/news\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en"},{"@type":"ImageObject","@id":"https:\/\/www.caribbeanvalueinvestor.com\/news\/ipos\/indies-pharma-ipo\/#primaryimage","inLanguage":"en","url":"https:\/\/www.caribbeanvalueinvestor.com\/news\/wp-content\/uploads\/2018\/07\/Indies-Pharma-IPO-logo-1.png","contentUrl":"https:\/\/www.caribbeanvalueinvestor.com\/news\/wp-content\/uploads\/2018\/07\/Indies-Pharma-IPO-logo-1.png","width":838,"height":416,"caption":"Indies Pharma IPO logo"},{"@type":"WebPage","@id":"https:\/\/www.caribbeanvalueinvestor.com\/news\/ipos\/indies-pharma-ipo\/#webpage","url":"https:\/\/www.caribbeanvalueinvestor.com\/news\/ipos\/indies-pharma-ipo\/","name":"Indies Pharma IPO- Is it a buy? - Caribbean Value Investor - Articles and Analysis","isPartOf":{"@id":"https:\/\/www.caribbeanvalueinvestor.com\/news\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.caribbeanvalueinvestor.com\/news\/ipos\/indies-pharma-ipo\/#primaryimage"},"datePublished":"2018-07-12T14:01:58+00:00","dateModified":"2018-07-12T14:06:24+00:00","description":"With the Indies Pharma IPO offer being fairly valued and only JMD $387,216,970.05 being sought with 39,500,000 shares available for the general public...","breadcrumb":{"@id":"https:\/\/www.caribbeanvalueinvestor.com\/news\/ipos\/indies-pharma-ipo\/#breadcrumb"},"inLanguage":"en","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.caribbeanvalueinvestor.com\/news\/ipos\/indies-pharma-ipo\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.caribbeanvalueinvestor.com\/news\/ipos\/indies-pharma-ipo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.caribbeanvalueinvestor.com\/news\/"},{"@type":"ListItem","position":2,"name":"Indies Pharma IPO- Is it a buy?"}]},{"@type":"Article","@id":"https:\/\/www.caribbeanvalueinvestor.com\/news\/ipos\/indies-pharma-ipo\/#article","isPartOf":{"@id":"https:\/\/www.caribbeanvalueinvestor.com\/news\/ipos\/indies-pharma-ipo\/#webpage"},"author":{"@id":"https:\/\/www.caribbeanvalueinvestor.com\/news\/#\/schema\/person\/cf4242964f6fec93f62c5580d1ae8c10"},"headline":"Indies Pharma IPO- Is it a buy?","datePublished":"2018-07-12T14:01:58+00:00","dateModified":"2018-07-12T14:06:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.caribbeanvalueinvestor.com\/news\/ipos\/indies-pharma-ipo\/#webpage"},"wordCount":631,"commentCount":1,"publisher":{"@id":"https:\/\/www.caribbeanvalueinvestor.com\/news\/#organization"},"image":{"@id":"https:\/\/www.caribbeanvalueinvestor.com\/news\/ipos\/indies-pharma-ipo\/#primaryimage"},"thumbnailUrl":"https:\/\/www.caribbeanvalueinvestor.com\/news\/wp-content\/uploads\/2018\/07\/Indies-Pharma-IPO-logo-1.png","keywords":["Caribbean Value Investor","GK Investments","Indies Pharma","IPO","Jamaica","Jamaican Stock Exchange","Pharmaceuticals","Prospectus","Sagicor Investments","stock market analysis"],"articleSection":["Financials","IPOs","Jamaica","Jamaica Stock Exchange","JSE","Retailers","stock market analysis"],"inLanguage":"en","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.caribbeanvalueinvestor.com\/news\/ipos\/indies-pharma-ipo\/#respond"]}]},{"@type":"Person","@id":"https:\/\/www.caribbeanvalueinvestor.com\/news\/#\/schema\/person\/cf4242964f6fec93f62c5580d1ae8c10","name":"Randy Aird","image":{"@type":"ImageObject","@id":"https:\/\/www.caribbeanvalueinvestor.com\/news\/#personlogo","inLanguage":"en","url":"https:\/\/secure.gravatar.com\/avatar\/544b04447358be67492969dc36891d4c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/544b04447358be67492969dc36891d4c?s=96&d=mm&r=g","caption":"Randy Aird"},"sameAs":["https:\/\/twitter.com\/RandyAird"],"url":"https:\/\/www.caribbeanvalueinvestor.com\/news\/author\/randy-aird\/"}]}},"_links":{"self":[{"href":"https:\/\/www.caribbeanvalueinvestor.com\/news\/wp-json\/wp\/v2\/posts\/435","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.caribbeanvalueinvestor.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.caribbeanvalueinvestor.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.caribbeanvalueinvestor.com\/news\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.caribbeanvalueinvestor.com\/news\/wp-json\/wp\/v2\/comments?post=435"}],"version-history":[{"count":4,"href":"https:\/\/www.caribbeanvalueinvestor.com\/news\/wp-json\/wp\/v2\/posts\/435\/revisions"}],"predecessor-version":[{"id":442,"href":"https:\/\/www.caribbeanvalueinvestor.com\/news\/wp-json\/wp\/v2\/posts\/435\/revisions\/442"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.caribbeanvalueinvestor.com\/news\/wp-json\/wp\/v2\/media\/441"}],"wp:attachment":[{"href":"https:\/\/www.caribbeanvalueinvestor.com\/news\/wp-json\/wp\/v2\/media?parent=435"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.caribbeanvalueinvestor.com\/news\/wp-json\/wp\/v2\/categories?post=435"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.caribbeanvalueinvestor.com\/news\/wp-json\/wp\/v2\/tags?post=435"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}